Orbis Allan Gray’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$114M Buy
+1,196,608
New +$128M 0.38% 55

Other funds holding RYTM

Orbis Allan Gray's RYTM Position: Q3 2026 in Review

Orbis Allan Gray opened a new position in Rhythm Pharmaceuticals (RYTM) in Q3 2026: 1,196,608 shares worth $114M. The stake represents 0.38% of the portfolio and ranks #55 among its holdings.

334 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Orbis Allan Gray held 1,196,608 shares of Rhythm Pharmaceuticals worth $114M as of Q3 2026.
  • Rhythm Pharmaceuticals was a new Orbis Allan Gray position in Q3 2026.
  • Rhythm Pharmaceuticals made up 0.38% of Orbis Allan Gray's portfolio in Q3 2026, its #55 holding.
  • 334 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Orbis Allan Gray's 13F filing for Q3 2026, filed 16 Nov 2026.